
Dofetilide is a class III antiarrhythmic agent. It is marketed under the trade name Tikosyn by Pfizer, and is available in the United States in capsules containing 125, 250, and 500 μg of dofetilide. It is not available in Europe or Australia.
{{Drugbox | verifiedrevid = 457790505 | IUPAC_name = N-[4-(2-{[2-(4-methane sulfonamidophenoxy)ethyl] (methyl)amino}ethyl)phenyl]methanesulfonamide | image = Dofetilide.svg | image_class = skin-invert-image
| tradename = Tikosyn | Drugs.com = | MedlinePlus = a601235 | pregnancy_category = | legal_status = | routes_of_administration =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).